-
Results of a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) indicate that most of the 1,000 women polled often confused myth with fact when quizzed about cervical cancer prevention.
-
Good news for your patients who use oral contraceptives (OCs): A new analysis of 45 epidemiological studies shows that use of such pills during a woman's lifetime gives substantial long-term protection against ovarian cancer.
-
Data released at a recent international conference suggest that adult male circumcision, which has been seen as possibly reducing the risk of HIV transmission in Africa, could raise the risk for women there whose male partners seek the procedure after they are infected.
-
The Food and Drug Administration (FDA) has revised labeling on the contraceptive patch (Ortho Evra, Ortho-McNeil-Janssen Pharmaceuticals; Raritan, NJ) to include new epidemiology data on the risks of venous thromboembolism (VTE).
-
I've Heard of TIA, But What The Heck is a TNA?, Advancing Insulin Therapy in Type 2 Diabetes Previously Treated with Glargine Plus Oral Agents, A Relationship Between Linolenic Acid and Neuropathy in Diabetics
-
The FDA has approved, after priority review, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV-1 infected adults who have failed other antiretroviral agents.
-
A study to determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women.
-
A physicians' survey in Connecticut indicates that a patient's socioeconomic status (SES) affected their clinical management decisions.
-
-
The frequency of false positive cardiac catheterization laboratory activation for suspected STEMI in community practice is relatively common with 14% of patients having no clear-cut culprit coronary artery lesions and 9.5% having no significant epicardial coronary artery disease.